bibliographicCitation |
Mahon FX, Hayette S, Lagarde V, Belloc F, Turcq B, Nicolini F, Belanger C, Manley PW, Leroy C, Etienne G, Roche S, Pasquet JM. Evidence that resistance to nilotinib may be due to BCR-ABL, Pgp, or Src kinase overexpression. Cancer Res. 2008 Dec 01;68(23):9809–16. doi: 10.1158/0008-5472.can-08-1008. PMID: 19047160. |